Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4 - Test2 - elhamkhani - TriplyDB

Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4

Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4

http://www.wikidata.org/entity/Q27648643

about

Prediction of co-receptor usage of HIV-1 from genotype Few and far between: how HIV may be evading antibody avidity Structural mechanism of trimeric HIV-1 envelope glycoprotein activation Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop CCR5 monoclonal antibodies for HIV-1 therapy Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors Structures of viral membrane proteins by high-resolution cryoEM Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition HIV-1 envelope glycoprotein structure Novel approaches to inhibit HIV entry Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity Structure determination of an anti-HIV-1 Fab 447-52D–peptide complex from an epitaxially twinned data set Structural and Biochemical Characterization of the Interaction between KPC-2 β-Lactamase and β-Lactamase Inhibitor Protein,Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based Immunogens Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1 Conserved structural elements in the V3 crown of HIV-1 gp120 Elicitation of structure-specific antibodies by epitope scaffolds Crystal Structure of HIV-1 Primary Receptor CD4 in Complex with a Potent Antiviral Antibody Structural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120 The Conformation and Orientation of a 27-Residue CCR5 Peptide in a Ternary Complex with HIV-1 gp120 and a CD4-Mimic Peptide Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals Structure-Based Design and Synthesis of an HIV-1 Entry Inhibitor Exploiting X-Ray and Thermodynamic Characterization Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops Heavy Chain-Only IgG2b Llama Antibody Effects Near-Pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of Coreceptor- and CD4-Binding Sites Rabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected Humans Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity Analysis of physicochemical and structural properties determining HIV-1 coreceptor usage

P2860

Q21090162-97E95642-CEB5-4052-8790-3150F1133587 Q21090507-F981E29C-DB38-431A-B58D-CFB08B53D684 Q21131394-730BACC9-F3F9-4716-8F9D-876C020B6111 Q21559473-59FEA418-96BF-4EC5-95E2-3DFD3113FB03 Q22242739-0CBCF6EC-25E5-4896-9378-91F46F89FFBD Q24598653-270909EC-D45B-4008-8E2D-7AF7D4028D04 Q24602061-941DD1A5-6A12-4B81-BA5E-8BE56EB44E88 Q24616040-3E30E03A-1A2E-4BA7-A1A1-B95713EED317 Q24619974-577031F3-410B-49A5-8F6A-9845E00DBBFF Q24655129-9E9C152E-3F78-42F0-B651-0908F51C90BD Q26852855-D2B74505-6995-44F0-9132-1B2566A7460C Q27004059-C65F25FB-9FE2-4DF6-A73C-169420548D2A Q27011248-D4FD917F-6564-4820-8559-EA215D5946AE Q27013957-27B30D64-D7A5-4B0A-82C8-95856D84E3F1 Q27309182-545F382E-D71B-4B9E-8F65-226292AD2051 Q27316899-8B140994-7D8D-4D75-A0C8-35CFC8F23170 Q27487974-6E334A35-A269-40BD-86D4-2E089C43C83B Q27646554-B2F75F5F-E375-4514-BF1E-3A4802644478 Q27650903-F4CE8C13-BB40-47AE-850E-DC1F26F6E6F0 Q27657333-823D7A31-7AAE-485A-A3B2-9BAB060C9420 Q27658173-2849E3AC-0255-4873-B0AB-C507CF0C0A90 Q27658989-4F2BC231-9C85-4D48-93E6-BB4B02EA9713 Q27660384-C2764CEA-A99D-446A-9300-4BAD85167629 Q27662155-0F7E745B-83E2-4721-8042-5702CB9AB455 Q27663325-8097FE04-9E72-4713-B452-CBB16F8CB942 Q27664711-7701975E-EE4A-4750-A35D-6981DD57E6A2 Q27666197-565D846C-7FFC-447D-840A-9E5139BE02F2 Q27667819-7AEA2A45-9AD2-46DF-8AED-B1B96480A7DC Q27670815-0A4CF630-BB81-4847-B4E3-5D378F0AE0D3 Q27675486-40779D4B-FBA3-488F-B4CB-9B1658A99D9C Q27677941-1D4084AD-ABE9-4AB8-B431-F887ACCB8A8E Q27678112-53DD1B4C-8689-42F9-972C-24773457F345 Q27678226-74AFF416-A548-441F-81BB-1654E26A0482 Q27679031-1228D5D8-A35A-4A94-9403-24C52B608AD8 Q27679123-AD7660C8-3A7A-4709-AAC4-D188CA27D091 Q27679932-49861FD6-F5AE-4E03-87FB-D0FDFFE63E4F Q28086826-E063B9EE-59E5-471F-A4EE-6385E390A36C Q28475912-795F80EE-F19B-4975-9C2C-19801C96E680 Q28485983-CF317DC1-49B7-4A3C-A3C2-CDDF47330AD2 Q28488611-8218DFF1-125B-4502-A406-2C9F5E060C0F

P2860

Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4

http://www.wikidata.org/entity/Q27648643

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@ast

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@en

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@nl

type

label

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@ast

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@en

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@nl

prefLabel

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@ast

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@en

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@nl

P1433

Q27648643-1DB88039-3A12-4FBF-B014-1D72B04AF1C9

P1476

Q27648643-7B5F5F64-9395-4485-80B3-4812DEB3886A

P2093

Q27648643-0651B217-4BD9-4A70-9683-28CC46366D93

Q27648643-0C890E11-679B-4D30-9E1D-3FB9BE5AD7D0

Q27648643-13E83AF6-2F13-4A2E-89AB-D196956477AA

Q27648643-398CE708-E4E2-4F2A-9E17-99CB06501E2E

Q27648643-3C446E0E-6CA7-498C-AB08-533303E0A93D

Q27648643-99960443-AFD2-4EEC-852C-010026189778

Q27648643-9C486C9F-1343-42E1-AE7F-9280A61E3D18

Q27648643-9CCE1AE2-237B-4BFC-B7F4-2C11888D1437

Q27648643-BB7B58CA-59D2-479A-B418-E03E5AAD49E6

Q27648643-C410803F-8C28-434D-97FB-5EE089562F1F

P2860

Q27648643-0918A3A5-87DB-47BC-9018-58435FAD759B

Q27648643-1E39AC30-2396-48D2-9133-8A48CDD15E86

Q27648643-1EF9ABBD-9794-4300-A397-1D61B838CD09

Q27648643-1F4EE9BC-A278-44B5-9D25-70463D2726FF

Q27648643-277C5A48-A843-4160-BDC8-99A417CA8750

Q27648643-355B6B0E-6EE7-4389-A603-2448910B25A0

Q27648643-3B94DF65-FF5D-4816-B5D3-139643F34D71

Q27648643-3FDEE90B-ABA8-4A0F-8F08-C3E4AAF47D9A

Q27648643-4528C17A-BACC-46DB-A212-7E2C1F70C3F8

Q27648643-4C6306AE-AB07-40F2-8780-CDBAC6479D4C

P304

Q27648643-69506021-4B92-4C69-B9A0-D86F6F174B66

P31

Q27648643-95C48985-1BCC-453C-B58A-2B44E3C50D70

P3181

Q27648643-D1374F69-D01A-4A8F-934B-24B5CCFFE010

P356

Q27648643-A1A2118F-9DD7-420E-B41D-5A621C2EBD13

P407

Q27648643-E23EA44B-7BE7-498F-B476-886765889EEF

P433

Q27648643-03CA7D96-8DD9-4110-BA9E-5A28444A1044

P478

Q27648643-4B5F9C30-12F7-4741-AAE3-793D155810C0

P50

Q27648643-642BBB0E-FE18-4D46-9BAE-D1AF121F44A5

Q27648643-DFFDFED9-DD1E-440C-87CE-311D063B7D60

P577

Q27648643-9D9FBC12-0BCF-4EC5-B731-FF6D52DE9B05

P5875

Q27648643-ED140863-2765-4AF3-A6A9-3B024308C92F

P698

Q27648643-841B312B-FB0F-421A-B904-4EF082488381

P921

Q27648643-7D6A25A1-BCB8-4C82-8BA1-822377B6E7BC

P932

Q27648643-C639F7F3-CD47-461B-85C5-178F92F9C78A

P3181

P356

SCIENCE.1145373

P1433

P1476

Structures of the CCR5 N Termi ...... ibody with HIV-1 gp120 and CD4

@en

P2093

Carole A Bewley

http://www.w3.org/2001/XMLSchema#string

Chih-Chin Huang

http://www.w3.org/2001/XMLSchema#string

James Robinson

http://www.w3.org/2001/XMLSchema#string

Min Tang

http://www.w3.org/2001/XMLSchema#string

Peter D Kwong

http://www.w3.org/2001/XMLSchema#string

Priyamvada Acharya

http://www.w3.org/2001/XMLSchema#string

Richard Wyatt

http://www.w3.org/2001/XMLSchema#string

Robyn L Stanfield

http://www.w3.org/2001/XMLSchema#string

Shi-Hua Xiang

http://www.w3.org/2001/XMLSchema#string

Son N Lam

http://www.w3.org/2001/XMLSchema#string

P2860

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

Molecular tinkering of G protein-coupled receptors: an evolutionary success

Crystal structure of rhodopsin: A G protein-coupled receptor

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

Structure of a V3-containing HIV-1 gp120 core

Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.

P304

1930-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4221835

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1145373

http://www.w3.org/2001/XMLSchema#string

P407

P433

5846

http://www.w3.org/2001/XMLSchema#string

P478

317

http://www.w3.org/2001/XMLSchema#string

P50

Ian Andrew Wilson

Joseph Sodroski

P577

2007-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5944099

http://www.w3.org/2001/XMLSchema#string

P698

17901336

http://www.w3.org/2001/XMLSchema#string

P921

P932

2278242

http://www.w3.org/2001/XMLSchema#string